2019年 5月 15日
With the European Medical Devices Regulation (MDR) coming into force in less than one year, plus related challenges such as Brexit, Notified Body capacity and Eudamed database implementation, manufacturers of CE-Marked devices have a lot to track in order to maintain European market compliance.
To help companies familiarize themselves with the latest European market and regulatory developments, we’ve summarized Emergo by UL blog coverage over the past several months for your review.
One of the MDR’s most significant impacts for medical device manufacturers will be on their clinical investigation and data obligations:
Manufacturers of CE-Marked devices anticipate having to begin entering Unique Device Identification (UDI) and related data into the European Eudamed database in 2020. Recent Eudamed-related coverage includes:
MDR requirements as well as the potential realization of a no-deal Brexit withdrawal of the UK from the European Union in October 2019 are also changing relationships between CE Mark holders and their Notified Body (NB) partners: